Testosterone Therapy in Relation to Prostate Cancer in a U.S. Commercial Insurance Claims Database.

Michael B CookDaniel C BeachlerLauren E Parlett Philip T CochettiWilliam D FinkleStephan LanesRobert N Hoover

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2019)

This study suggests that limited TT exposure does not increase risk of prostate cancer in the short term.

Keyphrases

prostate cancer
radical prostatectomy
health insurance
replacement therapy
stem cells
healthcare
emergency department
adverse drug
affordable care act
bone marrow
mesenchymal stem cells